×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Transparency, Expanded Access Navigator, Right to Try: Helping Patients Get Access to Investigational Medicines?
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Regulatory Affairs Americas
Bayer AG, United States
Numerous steps have been taken to increase access to investigational medicines for patients with serious and life-threatening diseases. This session will explore whether these initiatives have had the desired impact.
Learning Objective : Describe changes to expanded access programs, including Right to Try; Assess the impact of these changes to the patient; Discuss ways to improve access to investigational medicines for patients.
Speaker(s)
Patient Perspective on Preapproval Access
Melinda Bachini
Cholangiocarcinoma Foundation, United States
Advocacy Coordinator
Innovating Compassionate Use Request Processes with CompAC
Beverly L Harrison
Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Head, Patient Support
Assessment of Progress
Alison Bateman-House, PhD, MA, MPH
NYU Grossman School of Medicine, United States
Assistant Professor, Division of Medical Ethics, Dept of Population Health
Have an account?